Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C
Phase of Trial: Phase II/III
Latest Information Update: 05 Feb 2019
At a glance
- Drugs Eltrombopag (Primary) ; Boceprevir; Interferon; Ribavirin
- Indications Hepatitis C; Thrombocytopenia
- Focus Therapeutic Use
- Acronyms SQUELCH-C
- 28 Jan 2019 Status changed from recruiting to discontinued.
- 09 Apr 2013 New trial record
- 01 Apr 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.